Furthermore, over thirty scientists received specialised training on numerous aspects of
vaccine development, being provided with a thorough overview of the full
vaccine development process, and more than twenty innovative scientific papers were published from TRANSVAC's research and activities (for more information see also
tables below and: Geels, M. et al (2015): TRANSVAC research infrastructure — Results and lessons learned from the European network of
vaccine research and development.